Our Blog | Biosimilars & Generics | AAM

AAM All Access Podcast - Featuring AAM CEO Dan Leonard and Apotex President and CEO Jeff Watson

White Paper: Biosimilars in the U.S.: Reimbursement and Impacts to Uptake

Mar 25, 2021 | Craig Burton

New Analyses Point to Opportunities to Increase Savings from Biosimilar Adoption

Vice President Harris wears a blue blazer in front of three American flags as she announces her candidacy for Vice President in Wilmington, Delaware

Mar 25, 2021 | Katherine Raab

Women Continue to Make Health Policy History

Senior getting medicines at pharmacy counter

Mar 23, 2021 | Craig Burton

A Roadmap for Access

President Jimmy Carter signs a Presidential Proclamation designating the week of March 8, 1980, as the first National Women’s History Week

Mar 8, 2021 | Christine Simmon

Celebrating Women’s History Month

AAM Fit

Mar 2, 2021 | Erica Klinger

Healthy Competition in the Office—Even When We’re Not in the Office

Doctors and technology

Feb 5, 2021 | Erica Klinger

Cancer Costs and Options for Care in the United States

Dan Leonard, AAM President and CEO

Feb 4, 2021 | Dan Leonard

While We Await the Vaccine, We Can Trust in Generic Drugs

My Prescription for Savings. It’s time for Congress to take meaningful action to lower prescription drug costs with the Prescription for Savings. Patients win when market-based competition from FDA-approved generics and biosimilars deliver savings at the pharmacy counter.

Jan 29, 2021 | Kristin Murphy

AAM’s Recommendations to #SecureOurMeds

Jan 6, 2021 | Dan Leonard

2021 Generics and Biosimilars Outlook

Jean Hoffman

Jan 4, 2021 | Bob Billings

Thank you, Jean Hoffman

Helen, 41, from Florida, knows she can rely on biosimilars for her non-Hodgkin lymphoma

Dec 17, 2020 | Erica Klinger

Helen Knows She Can Rely on Biosimilars

GRx+Biosims 2020 Recap

Dec 17, 2020 | Erica Klinger

GRx+Biosims Recap: A Virtual Success